Cargando…
A genome‐wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells
Therapeutic resistance is a major clinical challenge in oncology. Evidence identifies cancer stem cells (CSCs) as a driver of tumor evolution. Accordingly, the key stemness property unique to CSCs may represent a reservoir of therapeutic target to improve cancer treatment. Here, we carried out a gen...
Autores principales: | Arfaoui, Abir, Rioualen, Claire, Azzoni, Violette, Pinna, Guillaume, Finetti, Pascal, Wicinski, Julien, Josselin, Emmanuelle, Macario, Manon, Castellano, Rémy, Léonard‐Stumpf, Candi, Bal, Anthony, Gros, Abigaelle, Lossy, Sylvain, Kharrat, Maher, Collette, Yves, Bertucci, Francois, Birnbaum, Daniel, Douik, Hayet, Bidaut, Ghislain, Charafe‐Jauffret, Emmanuelle, Ginestier, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783652/ https://www.ncbi.nlm.nih.gov/pubmed/31476112 http://dx.doi.org/10.15252/emmm.201809930 |
Ejemplares similares
-
HTS-Net: An integrated regulome-interactome approach for establishing network regulation models in high-throughput screenings
por: Rioualen, Claire, et al.
Publicado: (2017) -
BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells
por: Azzoni, Violette, et al.
Publicado: (2022) -
Breast cancer stem cells: tools and models to rely on
por: Charafe-Jauffret, Emmanuelle, et al.
Publicado: (2009) -
Targeting breast cancer stem cells: fishing season open!
por: Ginestier, Christophe, et al.
Publicado: (2010) -
p53 and cancer stem cells: The mevalonate connexion
por: Ginestier, Christophe, et al.
Publicado: (2012)